Aroa Biosurgery Limited

ASX:ARX Stok Raporu

Piyasa değeri: AU$182.8m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Aroa Biosurgery Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Brian Ward

İcra Kurulu Başkanı

NZ$1.1m

Toplam tazminat

CEO maaş yüzdesi54.1%
CEO görev süresi17.1yrs
CEO sahipliği9.6%
Yönetim ortalama görev süresi3.5yrs
Yönetim Kurulu ortalama görev süresi9.7yrs

Son yönetim güncellemeleri

Recent updates

Take Care Before Jumping Onto Aroa Biosurgery Limited (ASX:ARX) Even Though It's 29% Cheaper

Aug 22
Take Care Before Jumping Onto Aroa Biosurgery Limited (ASX:ARX) Even Though It's 29% Cheaper

Investors Aren't Entirely Convinced By Aroa Biosurgery Limited's (ASX:ARX) Revenues

Jun 12
Investors Aren't Entirely Convinced By Aroa Biosurgery Limited's (ASX:ARX) Revenues

Here's Why We're Not At All Concerned With Aroa Biosurgery's (ASX:ARX) Cash Burn Situation

Mar 25
Here's Why We're Not At All Concerned With Aroa Biosurgery's (ASX:ARX) Cash Burn Situation

Why Investors Shouldn't Be Surprised By Aroa Biosurgery Limited's (ASX:ARX) 25% Share Price Plunge

Jan 30
Why Investors Shouldn't Be Surprised By Aroa Biosurgery Limited's (ASX:ARX) 25% Share Price Plunge

Aroa Biosurgery Limited's (ASX:ARX) Revenues Are Not Doing Enough For Some Investors

Nov 14
Aroa Biosurgery Limited's (ASX:ARX) Revenues Are Not Doing Enough For Some Investors

Industry Analysts Just Made A Captivating Upgrade To Their Aroa Biosurgery Limited (ASX:ARX) Revenue Forecasts

Nov 02
Industry Analysts Just Made A Captivating Upgrade To Their Aroa Biosurgery Limited (ASX:ARX) Revenue Forecasts

Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 50% Above Its Share Price

Oct 25
Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 50% Above Its Share Price

We Think Aroa Biosurgery (ASX:ARX) Can Easily Afford To Drive Business Growth

May 13
We Think Aroa Biosurgery (ASX:ARX) Can Easily Afford To Drive Business Growth

Here's What Analysts Are Forecasting For Aroa Biosurgery Limited (ASX:ARX) After Its Annual Results

May 26
Here's What Analysts Are Forecasting For Aroa Biosurgery Limited (ASX:ARX) After Its Annual Results

An Intrinsic Calculation For Aroa Biosurgery Limited (ASX:ARX) Suggests It's 27% Undervalued

Mar 22
An Intrinsic Calculation For Aroa Biosurgery Limited (ASX:ARX) Suggests It's 27% Undervalued

Do Institutions Own Aroa Biosurgery Limited (ASX:ARX) Shares?

Feb 24
Do Institutions Own Aroa Biosurgery Limited (ASX:ARX) Shares?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Aroa Biosurgery Limited (ASX:ARX)

Feb 24
Don't Ignore The Fact That This Insider Just Sold Some Shares In Aroa Biosurgery Limited (ASX:ARX)

Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 44% Above Its Share Price

Dec 16
Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 44% Above Its Share Price

CEO Tazminat Analizi

Brian Ward'un ücretlendirmesi Aroa Biosurgery'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Mar 31 2024NZ$1mNZ$583k

-NZ$11m

Dec 31 2023n/an/a

-NZ$9m

Sep 30 2023n/an/a

-NZ$8m

Jun 30 2023n/an/a

-NZ$4m

Mar 31 2023NZ$1mNZ$552k

-NZ$396k

Dec 31 2022n/an/a

-NZ$1m

Sep 30 2022n/an/a

-NZ$2m

Jun 30 2022n/an/a

-NZ$5m

Mar 31 2022NZ$1mNZ$542k

-NZ$8m

Dec 31 2021n/an/a

-NZ$10m

Sep 30 2021n/an/a

-NZ$11m

Jun 30 2021n/an/a

-NZ$15m

Mar 31 2021NZ$2mNZ$483k

-NZ$19m

Tazminat ve Piyasa: Brian 'nin toplam tazminatı ($USD 679.57K ), Australian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 313.13K ).

Tazminat ve Kazançlar: Brian 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Brian Ward

17.1yrs

Görev süresi

NZ$1,078,619

Tazminat

Dr. Brian Ward, B.V.Sc, MBA(dist) has been Executive Director at Aroa Biosurgery Limited since September 21, 2007 and serves as its Managing Director and Chief Executive Officer. He has founded Aroa Biosur...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Brian Ward
Founderno dataNZ$1.08m9.6%
NZ$ 17.6m
James Agnew
CFO & Joint Company Secretary4.7yrsNZ$627.01kVeri yok
Rod Stanley
Chief Technology Officerless than a yearVeri yokVeri yok
Barnaby May
Chief Scientific Officer2.8yrsVeri yok0.95%
NZ$ 1.7m
Neetha Alex-Kumar
General Counselno dataVeri yokVeri yok
Frazer Murray
Director of Global Marketing & Strategyno dataVeri yokVeri yok
Yasmin Winchester
Vice President of Qualityno dataVeri yokVeri yok
Tracy Weimar
Joint Company Secretary4.3yrsVeri yokVeri yok
Adam Young
Vice President of Medical Affairsno dataVeri yokVeri yok

3.5yrs

Ortalama Görev Süresi

Deneyimli Yönetim: ARX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.5 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Brian Ward
Founder17.1yrsNZ$1.08m9.6%
NZ$ 17.6m
James McLean
Independent Non-Executive Chairperson13.2yrsNZ$212.19k0.82%
NZ$ 1.5m
John Diddams
Independent Non-Executive Director4.9yrsNZ$159.36k0.35%
NZ$ 632.1k
John Pinion
Independent Non-Executive Director9.7yrsNZ$187.52k0.14%
NZ$ 250.4k
Philip McCaw
Non-Executive Director16.6yrsNZ$130.68k5.68%
NZ$ 10.4m
Catherine Mohr
Independent Non-Executive Director1.9yrsNZ$178.02kVeri yok
Darla Hutton
Independent Non-Executive Directorless than a yearNZ$4.73k0.041%
NZ$ 74.3k

9.7yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ARX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.7 yıldır).